Literature DB >> 4155316

Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.

H Aström, H Vallin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4155316      PMCID： PMC458942          DOI： 10.1136/hrt.36.12.1194

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  9 in total

1.  EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors:  R S MCNEILL
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

Authors:  S J Sarnoff; E Braunwald; G H Welch; R B Case; W N Stainsby; R Macruz
Journal:  Am J Physiol       Date:  1958-01

3.  Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise.

Authors:  C R Jorgensen; K Wang; Y Wang; F L Gobel; R R Nelson; H Taylor
Journal:  Circulation       Date:  1973-12       Impact factor: 29.690

4.  Effects of I.C.I. 50172 in man during erect exercise.

Authors:  D Gibson; E Sowton
Journal:  Br Med J       Date:  1968-01-27

Review 5.  Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications.

Authors:  S E Epstein; E Braunwald
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

6.  Cardiac output after beta-adrenergic blockade in ischaemic heart disease.

Authors:  J Hamer; E Sowton
Journal:  Br Heart J       Date:  1965-11

7.  Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease.

Authors:  M F Rousseau; L A Brasseur; J M Detry
Journal:  Cardiovasc Res       Date:  1973-05       Impact factor: 10.787

8.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

9.  USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

Authors:  B N PRICHARD; P M GILLAM
Journal:  Br Med J       Date:  1964-09-19
  9 in total
  17 in total

Review 1.  Side effects and contraindications of beta-receptor blocking agents.

Authors:  H Lydtin
Journal:  Klin Wochenschr       Date:  1977-05-01

2.  Assessment and clinical implications of cardioselectivity.

Authors:  J L Wale; J D Fitzgerald
Journal:  Proc R Soc Med       Date:  1977

3.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

4.  Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.

Authors:  R J Northcote; D Ballantyne
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

5.  Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.

Authors:  T L Svendsen; O Hartling; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

6.  Effect in bronchial asthma of a new beta-adrenergic blocking drug atenolol (ICI 66, 082).

Authors:  N P Boye; J R Vale
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

7.  Haemodynamic effects of atenolol in patients with coronary artery disease.

Authors:  C Robinson; G Jackson; C Fisk; D Jewitt
Journal:  Br Heart J       Date:  1978-01

8.  Asthma and beta-blockers.

Authors:  D S Lawrence; J N Sahay; S S Chatterjee; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.

Authors:  J F De Plaen; A Amery; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

10.  Role of the Frank-Starling mechanism during maximal semisupine exercise after oral atenolol.

Authors:  K Andersen; H Vik-Mo
Journal:  Br Heart J       Date:  1982-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.